[1] | Guan Z, Lv S, Li SZ, et al. Endemic status of schistosomiasis in floating population and challenges in schistosomiasis control in China[J]. Chin J Parasitol Parasit Dis, 2017,35(6):598-603. (in Chinese) | [1] | ( 关周, 吕山, 李石柱, 等. 我国流动人口血吸虫病流行现状及防控挑战[J]. 中国寄生虫学与寄生虫病杂志, 2017,35(6):598-603.) | [2] | Zhang LJ, Xu ZM, Guo JY, et al. Endemic status of schistosomiasis in People’s Republic of China in 2018[J]. Chin J Schisto Control, 2019,31(6):576-582. (in Chinese) | [2] | ( 张利娟, 徐志敏, 郭婧怡, 等. 2018年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2019,31(6):576-582.) | [3] | Song LG, Wu ZD. Pathology and pathogenesis of liver fibrosis induced by Schistosoma japonicum[J]. Chin J Schisto Control, 2015,27(2):213-216, 220. (in Chinese) | [3] | ( 宋兰桂, 吴忠道. 日本血吸虫病肝纤维化的病理学及发病机制研究进展[J]. 中国血吸虫病防治杂志, 2015,27(2):213-216, 220.) | [4] | Kong DL, Zhou CL, Guo HF, et al. Praziquantel targets M1 macrophages and ameliorates splenomegaly in chronic schistosomiasis[J]. Antimicrob Agents Chemother, 2018,62(1):e00005-e00017. | [5] | Al-Quraishy S, Al-Khalifa MS, Dkhil MA. Role of berberine on schistosomiasis-inducted oxidative stress and damage in spleen of mice[J]. Life Sci J, 2013,10(4):135-139. | [6] | Wang YJ, Shen YJ, Xu YX, et al. Observation on destroyed architecture of splenic lymphoid follicles in mice infected with Schistosoma japonicum by immunohistochemistry[J]. Chin J Schisto Control, 2017,29(4):468-470. (in Chinese) | [6] | ( 王燕娟, 沈玉娟, 徐馀信, 等. 免疫组化法观察日本血吸虫感染破坏小鼠脾脏淋巴滤泡结构[J]. 中国血吸虫病防治杂志, 2017,29(4):468-470.) | [7] | Chen P, Wang SL. Analysis of multiple risk factors affecting postoperative complications in splenectomy[J]. J Hepat Surg, 2010,18(6):456-458. (in Chinese) | [7] | ( 陈平, 王胜利. 脾切除术后并发症发生相关危险因素分析[J]. 肝胆外科杂志, 2010,18(6):456-458.) | [8] | Mebius RE, Kraal G. Structure and function of the spleen[J]. Nat Rev Immunol, 2005,5(8):606-616. | [9] | Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation[J]. Nat Rev Immunol, 2008,8(12):958-969. | [10] | Funes SC, Rios M, Escobar-Vera J, et al. Implications of macrophage polarization in autoimmunity[J]. Immunology, 2018,154(2):186-195. | [11] | Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis[J]. J Hepatol, 2014,60(5):1090-1096. | [12] | Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury[J]. Front Physiol, 2012,3:56. | [13] | Yang WT, Tao YD, Wu Y, et al. Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair[J]. Nat Commun, 2019,10(1):1076. | [14] | Ramachandran P, Pellicoro A, Vernon MA, et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis[J]. Proc Natl Acad Sci USA, 2012,109(46):E3186-E3195. | [15] | Vale N, Gouveia MJ, Rinaldi G, et al. Praziquantel for schistosomiasis: single-drug metabolism revisited, mode of action, and resistance[J]. Antimicrob Agents Chemother, 2017,61(5):e02582-e02516. | [16] | Liang YJ, Luo J, Yuan Q, et al. New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum[J]. PLoS One, 2011,6(5):e20247. | [17] | Jiang A, Li ZF. Common causes of hypersplenism and perioperative management of splenectomy[J]. Chin J Hepat Surg, 2018,7(2):97-99. (in Chinese) | [17] | ( 蒋安, 李宗芳. 脾功能亢进常见原因及治疗策略[J]. 中华肝脏外科手术学电子杂志, 2018,7(2):97-99.) | [18] | Pellicoro A, Ramachandran P, Iredale JP, et al. Liver fibrosis and repair: immune regulation of wound healing in a solid organ[J]. Nat Rev Immunol, 2014,14(3):181-194. | [19] | Ramachandran P, Iredale JP. Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution[J]. J Hepatol, 2012,56(6):1417-1419. | [20] | Xu ZP, Zuo GP, Jin JL. Macrophage heterogeneity and its research progress in inflammation regulation[J]. J Cell Mol Immunol, 2015,31(12):1711-1714. (in Chinese) | [20] | ( 徐志鹏, 左国平, 靳建亮. 巨噬细胞异质性及其在炎症调控中的研究进展[J]. 细胞与分子免疫学杂志, 2015,31(12):1711-1714.) | [21] | Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells[J]. Annu Rev Immunol, 2009,27:669-692. | [22] | Baeck C, Wei X, Bartneck M, et al. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice[J]. Hepatology, 2014,59(3):1060-1072. | [23] | Yi L, Xin L, Qi L, et al. Effect of glycyrrhizic acid on bleomycin-induced pulmonary fibrosis[J]. Front Pharmacol, 2017,33(3):528-533. | [24] | Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease[J]. J Cell Physiol, 2018,233(9):6425-6440. | [25] | Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages[J]. Immunity, 2014,41(1):21-35. | [26] | Liaskou E, Zimmermann HW, Li KK, et al. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics[J]. Hepatology, 2013,57(1):385-398. | [27] | Wolf Y, Shemer A, Polonsky M, et al. Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation[J]. J Exp Med, 2017,214(4):905-917. | [28] | Li ZF, Gao J, Zhang S, et al. The observation of quantity and phagocytosis of splenic macrophages in patients with portal hypertension-associated hypersplenism[J]. Chin J Exp Surg, 2006,23(11):1288-1290. (in Chinese) | [28] | ( 李宗芳, 高君, 张澍, 等. 门静脉高压症脾亢脾巨噬细胞数量及其吞噬功能的观察[J]. 中华实验外科杂志, 2006,23(11):1288-1290.) | [29] | Liang YS. Studies on resistance of Schistosoma to praziquantel in China[J]. Chin Trop Med, 2019,19(7):603-607. (in Chinese) | [29] | ( 梁幼生. 我国血吸虫对吡喹酮抗药性研究之概要[J]. 中国热带医学, 2019,19(7):603-607.) |
|